JACOBS LEVY EQUITY MANAGEMENT, INC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 107 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$1,591,000
+42.3%
535,836
+115.1%
0.01%
+57.1%
Q4 2021$1,118,000
+1315.2%
249,069
+1438.9%
0.01%
+600.0%
Q3 2021$79,000
-82.3%
16,185
-74.4%
0.00%
-66.7%
Q1 2021$446,000
+92.2%
63,210
+70.9%
0.00%
+50.0%
Q4 2020$232,000
-53.5%
36,990
-24.4%
0.00%
-75.0%
Q2 2018$499,000
-10.4%
48,900
+14.2%
0.01%
-11.1%
Q1 2018$557,000
+144.3%
42,830
+236.4%
0.01%
+125.0%
Q4 2017$228,00012,7300.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
AIGH Capital Management LLC 2,339,107$10,502,0003.20%
Telemetry Investments, L.L.C. 262,279$1,178,0001.52%
Bruce & Co., Inc. 1,443,312$6,480,0001.30%
Omega Fund Management, LLC 1,971,241$8,851,0001.25%
Worth Venture Partners, LLC 556,832$2,500,0001.24%
Abingworth LLP 1,041,131$4,654,0001.13%
1492 Capital Management LLC 491,033$2,205,0001.09%
CM Management, LLC 300,000$1,347,0001.02%
Trellus Management Company, LLC 295,000$1,325,0000.88%
GENERAL AMERICAN INVESTORS CO INC 1,306,919$5,868,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders